Why is Gland Pharma falling/rising?

As of 04-Jul, Gland Pharma Ltd's stock price is currently at 1,870.00, reflecting a slight increase of 1.0 (0.05%). The stock has been gaining for the last two days, with a total rise of 0.2% during this period. In terms of performance, Gland Pharma has outperformed the benchmark over the past week and month, with returns of +4.64% and +15.17%, respectively, while the Sensex has seen declines of -0.74% and an increase of +3.01%. The company benefits from a low debt-to-equity ratio and high institutional holdings at 40.18%, which suggests strong confidence from knowledgeable investors, contributing positively to its recent price movement.
In the broader market context, Gland Pharma's short-term performance has been notably stronger than the Sensex, particularly over the past week and month. While the stock has underperformed its sector by -0.46% today, the overall liquidity remains healthy, with a significant increase in delivery volume, indicating rising investor participation. Despite a longer-term underperformance compared to the benchmark over three years, the recent trends suggest a positive sentiment towards Gland Pharma, bolstered by its solid fundamentals and institutional backing.